Evidence map›Paper›PMID 28175301›Full record

ArticleHuman molecular genetics2017

Mutations in MSH5 in primary ovarian insufficiency.

Ting Guo, Shidou Zhao, Shigang Zhao, Min Chen, Guangyu Li, Xue Jiao, Zhao Wang, Yueran Zhao, Yingying Qin, Fei Gao and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Double jeopardy: howFrontiers in cell and developmental biology · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Advances in the genetic etiology of female infertility.Journal of assisted reproduction and genetics · 2024
    Review
  11. Genetic insights into the complexity of premature ovarian insufficiency.Reproductive biology and endocrinology : RB&E · 2024
    Review
  12. Article
  13. Article
  14. A Human HomozygousGenes · 2024
    Article
  15. Review
  16. Review
  17. Mechanisms of ovarian aging in women: a review.Journal of ovarian research · 2023
    Review
  18. Article
  19. Selected Genetic Factors Associated with Primary Ovarian Insufficiency.International journal of molecular sciences · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ting GuoRenji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, P.R. China.
Shidou ZhaoCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Shigang ZhaoCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Min ChenState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, P.R. China.
Guangyu LiCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Xue JiaoCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Zhao WangCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Yueran ZhaoCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Yingying QinCenter for Reproductive Medicine, Shandong University, Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, The Key laboratory for Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong 250021, P.R. China.
Fei GaoState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, P.R. China.
Zi-Jiang ChenRenji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, P.R. China.
Shandong University · CNShandong Provincial Hospital · CNChinese Academy of Sciences · CNRenji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary ovarian insufficiency (POI) is a genetically heterogeneous disorder that occurs in familial or sporadic fashion. Through whole exome sequencing in a Chinese pedigree with POI, we identified a novel homozygous missense mutation (ENST00000375755: c.1459G > T, p.D487Y) in the MSH5 gene in two sisters with POI. The homologous mutation in mice resulted in atrophic ovaries without oocytes, and in vitro functional study revealed that mutant MSH5 impaired DNA homologous recombination repair. From sanger sequencing of MSH5 in 200 sporadic POI patients, we identified three heterozygous mutations (ENST00000375755: c.1057C > A, p.L353M; c.1459G > T, p.D487Y and c.2107 A > G, p.I703V). Considering the heterozygous p.D487Y carrier in the POI pedigree was fertile, the causality of the three heterozygous mutations in POI need more evidence. Our studies confirmed that perturbation of genes involved in DNA damage repair could lead to non-syndromic POI. The underlying mechanism-inability to repair DNA damage-will receive increasing attention with respect to POI.

Indexed as

AdultAnimalsBase SequenceCell Cycle ProteinsExomeFemaleHeterozygoteHomozygoteHumansMaleMiceMutation, MissensePedigreePrimary Ovarian InsufficiencySiblingsCell Cycle ProteinsMSH5 protein, human

Identifiers

PMID28175301
PMCPMC5393145
OpenAlexW2586352344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.